Screening for occult faecal blood loss in a community by means of Hemoccult II slides and a tetramethylbenzidine test.
A total of 754 persons statistically selected from the age group 54-64 years were asked by letter to provide faecal samples for screening of occult blood during dietary restrictions. A total of 413 persons (55%) returned an average of 5.8 (range, 1-6) faecal samples each. All the faecal specimens were analysed with Hemoccult II slides and the 3,3',5,5'-tetramethylbenzidine (TMB) test 0.10%. For technical reasons, however, the Hemoccult test could not be evaluated. The TMB test showed faecal blood in 50 persons. A case history was obtained in 49 persons, of whom 47 agreed to further clinical, radiological, and endoscopic investigations. The most important findings in these examinations were resectable colonic carcinoma (Dukes's stage B) in 1 subject, a gastric ulcer in 1, haemorrhagic gastritis in 1, duodenal ulcers in 2, and colorectal polyps in 11 persons. The cost of the study was estimated to be NOK 114,000 (about USD 16,000).
D001560:Benzidines; D003110:Colonic Neoplasms / Q000453:epidemiology; D003365:Costs and Cost Analysis; D004032:Diet; D005767:Gastrointestinal Diseases / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D009664:Norway; D009780:Occult Blood
D001560:Benzidines; C021758:3,3',5,5'-tetramethylbenzidine